Role of Noninvasive Biomarkers in the Diagnosis of Nonalcoholic Steatohepatitis With Stage 2 or 3 Fibrosis

G&H Why is the stage of fibrosis important in nonalcoholic steatohepatitis? RL Patients with nonalcoholic fatty liver disease (NAFLD) can be divided into 2 broad […]

Screening for Nonalcoholic Fatty Liver Disease in the Primary Care Clinic

Abstract: Nonalcoholic fatty liver disease (NAFLD) is a spectrum of diseases ranging from simple hepatic steatosis to nonalcoholic steatohepatitis (NASH) to advanced fibrosis and cirrhosis […]

Implications of Nonalcoholic Fatty Liver Disease on Pregnancy and Maternal and Child Outcomes

Abstract: With an estimated 10% prevalence of nonalcoholic fatty liver disease (NAFLD) among women of childbearing age, it is important to understand the implications of this […]

Diagnostic and Treatment Implications of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Abstract: Nonalcoholic fatty liver disease (NAFLD) affects 75 to 100 million adults in the United States and is the leading cause of chronic liver disease […]

Overview of Updated Practice Guidelines for Pediatric Nonalcoholic Fatty Liver Disease

Abstract: Nonalcoholic fatty liver disease (NAFLD) is a form of chronic liver disease that is characterized by excessive fatty infiltration of the liver in the […]